Genetic Analysis AS has coverage from the below listed analysts.
Analyst Jan Glevén
Mangold Fondskommision has issued the following report for the GEAN share:
Analyst Gediminas Ruginis
Please note that related to valuation, Norne Securities only issue a range, and not a target. As Norne Securities state in the reports, this is due to the services being Paid Research, Norne Securities will, under current legislation (Norwegian), not provide a specific research recommendation with respect to the Company’s shares, but will provide a fair value estimate range, from conservative to optimistic, in accordance with market practice for such research.
Norne Securities has issued the following reports for the GEAN share: